Nanocovax vaccine produced by Nanogen (Source: vneconomy.vn) Hanoi (VNA) – Vietnam can satisfy vaccine production requirements once it obtains
vaccine patents, an officer has affirmed.
Domestic vaccine
production would be an opportunity for Vietnam to soon reach herd immunity and even
cover exports in the future, Major General Nguyen Viet Luong, Political
Commissar of the Vietnam Military Medical University, which is participating in
COVID-19 vaccine development, told the Vietnam News Agency (VNA).
He suggested that countries
temporarily waive vaccine patents to contribute to the fight against the
pandemic.
Four vaccines are
under development in Vietnam, by the Nanogen Pharmaceutical Biotechnology JSC,
the Institute of Vaccines and Medical Biologicals, the Vaccine and Biological
Production Company No 1, and Polyvac.
Of these, the
Pharmaceutical Biotechnology JSC’s NanoCovax, whose second phase of human
trials has been completed, is the most feasible and will soon be approved for
emergency use, Luong continued.
The company can
produce 2-3 million doses monthly, he said.
Major General , Political Commissar of the Vietnam Military Medical University (Photo: VNA)manufacturing requires standardised technologies and other factors relating to the
environment, workforce, and, most notably, materials.
Luong highlighted
the Government and Ministry of Health’s sound vaccine import strategy, which together
with patent-based production and local research and production would help
Vietnam reach herd immunity in late 2021 or mid-2022.
However, he added,
domestic vaccine research and production will remain a long-term pillar as
Vietnam will need a large quantity of vaccines annually for its population of
nearly 100 million./.
Source: VietnamPlus
